Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Gene | BARD1 |
Variant | A460T |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | BARD1 A460T lies within ANK repeat 2 of the Bard1 protein (UniProt.org). A460T results in decreased homology-directed DNA repair activity, leads to increased sensitivity to DNA damaging agents in cell culture (PMID: 30925164). |
Associated Drug Resistance | |
Category Variants Paths |
BARD1 mutant BARD1 inact mut BARD1 A460T |
Transcript | NM_000465.4 |
gDNA | chr2:g.214769249C>T |
cDNA | c.1378G>A |
Protein | p.A460T |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_047445350.1 | chr2:g.214769249C>T | c.1378G>A | p.A460T | RefSeq | GRCh38/hg38 |
NM_000465.3 | chr2:g.214769249C>T | c.1378G>A | p.A460T | RefSeq | GRCh38/hg38 |
NM_000465 | chr2:g.214769249C>T | c.1378G>A | p.A460T | RefSeq | GRCh38/hg38 |
NM_000465.4 | chr2:g.214769249C>T | c.1378G>A | p.A460T | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
BARD1 A460T | cervical cancer | sensitive | Cisplatin | Preclinical - Cell culture | Actionable | In a preclinical study, cisplatin treatment of HeLa cells expressing Bard1 A460T were more sensitive than wild-type Bard1 expressing cells, as demonstrated by decreased colony formation (PMID: 30925164). | 30925164 |